Novartis set to divest Indian eyecare portfolio to JB Chemicals
NEW DELHI: Drug major Novartis is planning to divest its Indian eyecare portfolio to Mumbai-based JB Chemicals, in a deal estimated to be around Rs 1,000 crore.The Novartis spin-off will … Read More